Litcius/Paper detail

High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker

F. Kommoss, Lisa-Marie Mar, Brooke E. Howitt, Krisztina Hanley, Gulisa Turashvilli, Rolf Buslei, Julie Irving, Brendan C. Dickson, Christian Koelsche, Hans‐Peter Sinn, Peter Schirmacher, Andreas von Deimling, Sarah Chiang, W. Glenn McCluggage, Sabrina Croce, Colin J.R. Stewart, Cheng‐Han Lee

2023Modern Pathology26 citationsDOI

Topics & Concepts

CDKN2AFluorescence in situ hybridizationBiologyFusion geneCancer researchCarcinogenesisPathologyImmunohistochemistryEndometrial stromal sarcomaStromal cellCancerGeneMedicineChromosomeGeneticsSarcoma Diagnosis and TreatmentCancer Genomics and DiagnosticsRenal and related cancers
High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker | Litcius